TFF2 and COVID-19: Here, using clinical evidence in tandem with proof-of-principle based in vitro and in vivo animal experiments, we assess whether the COVID-19 mRNA VE is altered through impaired Sp antigen translation in IC SOT patients that are on immunosuppressive medications.